Cargando…
Correlation of TTF-1 immunoexpression and EGFR mutation spectrum in non–small cell lung carcinoma
BACKGROUND: Thyroid transcription factor (TTF-1) is a diagnostic marker expressed in 75%–85% of primary lung adenocarcinomas (ACs). Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene is the most common targetable driver alteration in lung AC. Previ...
Autores principales: | Nakra, Tripti, Singh, Varsha, Nambirajan, Aruna, Malik, Prabhat Singh, Mohan, Anant, Jain, Deepali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pathologists and the Korean Society for Cytopathology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353134/ https://www.ncbi.nlm.nih.gov/pubmed/34233113 http://dx.doi.org/10.4132/jptm.2021.05.10 |
Ejemplares similares
-
Mapping the immune landscape in small cell lung cancer by analysing expression of immuno-modulators in tissue biopsies and paired blood samples
por: Dutta, Rimlee, et al.
Publicado: (2023) -
Immunoexpression of TTF1 and p63 Differentiates Lung Adenocarcinomas in Sputum Samples
por: Veena, V. S., et al.
Publicado: (2021) -
Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review
por: Singh, Priyanka, et al.
Publicado: (2022) -
The Relationship between TTF-1 Expression and EGFR Mutations in Lung Adenocarcinomas
por: Shanzhi, Wan, et al.
Publicado: (2014) -
EGFR Immunoexpression
in Laryngeal Squamous Cell Carcinoma
por: CERCELARU, LILIANA, et al.
Publicado: (2017)